French medical insurance deficit down by a half:
This article was originally published in Clinica
Executive Summary
The French medical insurance deficit has been reduced by more than half since 1996. The outstanding deficit now stands at Fr15.9 billion ($2.6 billion). By the end of 1998 this is expected to have gone down to Fr12.8 billion, reports Les Echos. However, medical insurance spending next year is expected to rise by 2.2%.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.